Company Quick10K Filing
Cray
10-Q 2019-06-30 Filed 2019-08-02
10-Q 2019-03-31 Filed 2019-05-07
10-K 2018-12-31 Filed 2019-02-12
10-Q 2018-09-30 Filed 2018-10-30
10-Q 2018-06-30 Filed 2018-07-31
10-Q 2018-03-31 Filed 2018-05-01
10-K 2017-12-31 Filed 2018-02-15
10-Q 2017-09-30 Filed 2017-10-30
10-Q 2017-06-30 Filed 2017-07-27
10-Q 2017-03-31 Filed 2017-05-02
10-K 2016-12-31 Filed 2017-02-10
10-Q 2016-09-30 Filed 2016-11-07
10-Q 2016-06-30 Filed 2016-08-02
10-Q 2016-03-31 Filed 2016-05-03
10-K 2015-12-31 Filed 2016-02-11
10-Q 2015-09-30 Filed 2015-10-29
10-Q 2015-06-30 Filed 2015-07-30
10-Q 2015-03-31 Filed 2015-05-05
10-K 2014-12-31 Filed 2015-02-19
10-Q 2014-09-30 Filed 2014-10-28
10-Q 2014-06-30 Filed 2014-07-29
10-Q 2014-03-31 Filed 2014-04-29
10-K 2013-12-31 Filed 2014-02-13
10-Q 2013-09-30 Filed 2013-11-12
10-Q 2013-06-30 Filed 2013-07-31
10-K 2012-12-31 Filed 2013-02-28
10-Q 2012-09-30 Filed 2012-11-09
10-Q 2012-06-30 Filed 2012-07-31
10-Q 2012-03-31 Filed 2012-04-26
10-K 2011-12-31 Filed 2012-02-27
10-Q 2011-09-30 Filed 2011-11-01
10-Q 2011-06-30 Filed 2011-07-28
10-Q 2011-03-31 Filed 2011-05-09
10-K 2010-12-31 Filed 2011-03-04
10-Q 2010-09-30 Filed 2010-11-08
10-Q 2010-06-30 Filed 2010-08-06
10-Q 2010-03-31 Filed 2010-05-07
10-K 2009-12-31 Filed 2010-03-16
8-K 2019-09-25
8-K 2019-09-20
8-K 2019-08-27
8-K 2019-08-16
8-K 2019-08-13
8-K 2019-08-02
8-K 2019-06-23
8-K 2019-06-11
8-K 2019-05-16
8-K 2019-05-07
8-K 2019-05-07
8-K 2019-02-20
8-K 2019-02-12
8-K 2019-01-14
8-K 2018-10-30
8-K 2018-07-31
8-K 2018-06-12
8-K 2018-05-01
8-K 2018-04-20
8-K 2018-02-15
8-K 2018-01-16

Cray Financials

CRAY Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
Ameren Illinois Co (AILNP)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
Supernova Partners Acquisition Co III, Ltd. (STRE-WT)
30DC (TDCH)
Ameri Metro, Inc. (formerly Yellowwood) (ARMT)
Gores Technology Partners, Inc. (GTPAW)
Bioquest Corp (BQST)
BriaCell Therapeutics Corp. (BCTXW)
3D Total Solutions (DTLS)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash1328850109219228253165149571931881218311311968190267294213144223198171152137137144184246222165
Accounts Receivable2026726410222135925451835977451658113714312560561101985575631629611375886677
Inventory48959812113216990791262069511819219814421022123011412219724488114156198186181148142808188
PP&E17171616172110926272712431313194343532102313028903837381023738361123638
Assets245256283351512535510476503501603576606543651644660768694689696723715669701667619541520506517500460
Accounts Payable235138553761353362573436764349617870284672664631564257221729332530
Long-Term Debt
Liabilities103122116178185210170138164178228210248168198191202300202181197245189160198173218162149156174183183
Stockholders' Equity142134167173327324341338338323376366359376454453458468493508500478525509503494400379371350343318276
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue6837921121603618980128543075586159262801861912671061007734759878016780120931637269
Cost of Revenue4220566796181355595341943756111173561371261816664542263559511175382681234645
Gross Profit26163545631754242720113182949892450668640362412024282850273825402624
R&D181872423242325222025292627293033172722302926303637
SG&A101011131810201719162517192125192023272324232823222023212122242031
Tax0004420210-01100147101-2-5111-4-710200001
Net Income-3-12315165-514-8-0-1151-13-7775-961120-5-13-2352-19-7-10-98-25-11-22-13-29-43
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating-42-3758-326170-726-1088761-63-6693-421077934-94-738170-28-80-35-1141-21-51
Cash Investing-1-1-0138-53-46-17-221749-67-329182-717-4-9147-3-9626119-16-0-4-4
Cash Financing0115111-1-101-1-0100-312-1-200-1001-2-01-2